Differentiated Preclinical Lead Candidate STAR-0310 to be Developed as a Potential Best-in-Class Long-Acting Treatment for Atopic Dermatitis – Conference Call and Webcast to be Held on October 12, 2023 at 8:30am ET BOSTON (BUSINESS WIRE) Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company f.
Astria Therapeutics Announces Exclusive Worldwide License Agreement with Ichnos Sciences for OX40 Portfolio streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.